Literature DB >> 25616604

The prognostic value of CSF neurofilaments in multiple sclerosis at 15-year follow-up.

Axel Petzold1.   

Abstract

Entities:  

Keywords:  BIOCHEMISTRY; CSF; MULTIPLE SCLEROSIS; NEUROCHEMISTRY; NEUROIMMUNOLOGY

Mesh：

Substances：

Year:  2015        PMID： 25616604     DOI： 10.1136/jnnp-2014-309827

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  12 in total

1.  IL-2, IL-6 and chitinase 3-like 2 might predict early relapse activity in multiple sclerosis.

Authors:  Marko Petržalka; Eva Meluzínová; Jana Libertínová; Hana Mojžišová; Jitka Hanzalová; Petra Ročková; Martin Elišák; Silvia Kmetonyová; Jan Šanda; Ondřej Sobek; Petr Marusič
Journal:  PLoS One       Date:  2022-06-27       Impact factor: 3.752

Review 2.  Neurofilaments as Biomarkers for Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis.

Authors:  Zhouwei Xu; Robert David Henderson; Michael David; Pamela Ann McCombe
Journal:  PLoS One       Date:  2016-10-12       Impact factor: 3.240

Review 3.  Outcome Measures in Clinical Trials for Multiple Sclerosis.

Authors:  Caspar E P van Munster; Bernard M J Uitdehaag
Journal:  CNS Drugs       Date:  2017-03       Impact factor: 5.749

Review 4.  Neurofilament light chain as a biological marker for multiple sclerosis: a meta-analysis study.

Authors:  Laisheng Cai; Jingwei Huang
Journal:  Neuropsychiatr Dis Treat       Date:  2018-09-03       Impact factor: 2.570

5.  A motor neuron strategy to save time and energy in neurodegeneration: adaptive protein stoichiometry.

Authors:  Elisabetta Zucchi; Ching-Hua Lu; Yunju Cho; Rakwoo Chang; Rocco Adiutori; Irene Zubiri; Mauro Ceroni; Cristina Cereda; Orietta Pansarasa; Linda Greensmith; Andrea Malaspina; Axel Petzold
Journal:  J Neurochem       Date:  2018-09       Impact factor: 5.372

Review 6.  Biomarkers of multiple sclerosis: current findings.

Authors:  Violaine K Harris; John F Tuddenham; Saud A Sadiq
Journal:  Degener Neurol Neuromuscul Dis       Date:  2017-01-12

7.  Neurofilament light chain serum levels correlate with 10-year MRI outcomes in multiple sclerosis.

Authors:  Tanuja Chitnis; Cindy Gonzalez; Brian C Healy; Shrishti Saxena; Mattia Rosso; Christian Barro; Zuzanna Michalak; Anu Paul; Pia Kivisakk; Camilo Diaz-Cruz; Neda Sattarnezhad; Isabelle V Pierre; Bonnie I Glanz; Davorka Tomic; Harald Kropshofer; Dieter Häring; David Leppert; Ludwig Kappos; Rohit Bakshi; Howard L Weiner; Jens Kuhle
Journal:  Ann Clin Transl Neurol       Date:  2018-10-16       Impact factor: 4.511

8.  Profiling individual clinical responses by high-frequency serum neurofilament assessment in MS.

Authors:  Katja Akgün; Nicole Kretschmann; Rocco Haase; Undine Proschmann; Hagen H Kitzler; Heinz Reichmann; Tjalf Ziemssen
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2019-04-08

9.  Serum neurofilament is associated with progression of brain atrophy and disability in early MS.

Authors:  Jens Kuhle; Bardia Nourbakhsh; Donna Grant; Steve Morant; Christian Barro; Özgür Yaldizli; Daniel Pelletier; Gavin Giovannoni; Emmanuelle Waubant; Sharmilee Gnanapavan
Journal:  Neurology       Date:  2017-02-01       Impact factor: 9.910

10.  Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis.

Authors:  Giulio Disanto; Christian Barro; Pascal Benkert; Yvonne Naegelin; Sabine Schädelin; Antonella Giardiello; Chiara Zecca; Kaj Blennow; Henrik Zetterberg; David Leppert; Ludwig Kappos; Claudio Gobbi; Jens Kuhle
Journal:  Ann Neurol       Date:  2017-06       Impact factor: 10.422
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.